<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39411709</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48.</ArticleTitle><Pagination><StartPage>1427284</StartPage><MedlinePgn>1427284</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1427284</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1427284</ELocationID><Abstract><AbstractText>With the prevalence of sequentially-emerged sublineages including BA.1, BA.2 and BA.5, SARS-CoV-2 Omicron infection has transformed into a regional epidemic disease. As a sublineage of BA.5, the BA.5.2.48 outbroke and evolved into multi-subvariants in China without clearly established virological characteristics. Here, we evaluated the virological characteristics of two isolates of the prevalent BA.5.2.48 subvariant, DY.2 and DY.1.1 (a subvariant of DY.1). Compared to the normal BA.5 spike, the double-mutated DY.1.1 spike demonstrates efficient cleavage, reduced fusogenicity and higher hACE2 binding affinity. BA.5.2.48 demonstrated enhanced airborne transmission capacity than BA.2 in hamsters. The pathogenicity of BA.5.2.48 is greater than BA.2, as revealed in Omicron-lethal H11-K18-hACE2 rodents. In both naïve and convalescent hamsters, DY.1.1 shows stronger fitness than DY.2 in hamster turbinates. Thus regional outbreaking of BA.5.2.48 promotes the multidirectional evolution of its subvariants, gaining either enhanced pathogenicity or a fitness in upper airways which is associated with higher transmission.</AbstractText><CopyrightInformation>Copyright © 2024 Wang, Jin, Liu, Zeng, Zhu, Li, Wang, Xiang, Zhang, Chen, Gao, Lai, Yan, Xia, Li, Wang and Gao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Wenqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northeast Normal University, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jin</LastName><ForeName>Qiushi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Ruixue</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zeng</LastName><ForeName>Wentao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tiecheng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Senior Cadre Department, The 964(th) Hospital of Joint Logistics Support, Chinese People's Liberation Army (PLA), Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xianzhu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jianmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Reproductive Medicine and Offspring Health, Jiangsu Laboratory Animal Center, Jiangsu Animal Experimental Center of Medicine and Pharmacy, Department of Cell Biology, Animal Core Facility, Key Laboratory of Model Animal, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuefeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BA.5</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">animal models</Keyword><Keyword MajorTopicYN="N">pathogenicity</Keyword><Keyword MajorTopicYN="N">spike</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411709</ArticleId><ArticleId IdType="pmc">PMC11473351</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1427284</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. . Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. (2022) 608:603–8. doi: 10.1038/s41586-022-05053-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05053-w</ArticleId><ArticleId IdType="pmc">PMC9385487</ArticleId><ArticleId IdType="pubmed">35790190</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al. . Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. (2022) 185:2422–2433.e13. doi: 10.1016/j.cell.2022.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9181312</ArticleId><ArticleId IdType="pubmed">35772405</ArticleId></ArticleIdList></Reference><Reference><Citation>Uraki R, Halfmann PJ, Iida S, Yamayoshi S, Furusawa Y, Kiso M, et al. . Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature. (2022) 612:540–5. doi: 10.1038/s41586-022-05482-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05482-7</ArticleId><ArticleId IdType="pubmed">36323336</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai H, Chan JF-W, Hu B, Chai Y, Yoon C, Liu H, et al. . The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. eBioMedicine. (2023) 95:104753. doi: 10.1016/j.ebiom.2023.104753</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104753</ArticleId><ArticleId IdType="pmc">PMC10448076</ArticleId><ArticleId IdType="pubmed">37579626</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, et al. . Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Commun Biol. (2023) 6:772. doi: 10.1038/s42003-023-05081-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-05081-w</ArticleId><ArticleId IdType="pmc">PMC10366110</ArticleId><ArticleId IdType="pubmed">37488344</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. Moving away from zero COVID in China. Lancet Respir Med. (2023) 11:132. doi: 10.1016/S2213-2600(22)00508-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00508-2</ArticleId><ArticleId IdType="pmc">PMC9757876</ArticleId><ArticleId IdType="pubmed">36535298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Wang L, Feng Z, Xu H, Li F, Shen Y, et al. . Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. Lancet. (2023) 401:664–72. doi: 10.1016/S0140-6736(23)00129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00129-0</ArticleId><ArticleId IdType="pmc">PMC9949854</ArticleId><ArticleId IdType="pubmed">36773619</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gisaid . SARS-coV-2 phylodynamics in China (2024). Available online at: https://gisaid.org/phylodynamics/China-cn. (August 31, 2023).</Citation></Reference><Reference><Citation>Kimura I, Yamasoba D, Tamura T, Nao N, Suzuki T, Oda Y, et al. . Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell. (2022) 185:3992–4007.e16. doi: 10.1016/j.cell.2022.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.018</ArticleId><ArticleId IdType="pmc">PMC9472642</ArticleId><ArticleId IdType="pubmed">36198317</ArticleId></ArticleIdList></Reference><Reference><Citation>Barut GT, Halwe NJ, Taddeo A, Kelly JN, Schön J, Ebert N, et al. . The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nat Commun. (2022) 13:5929. doi: 10.1038/s41467-022-33632-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33632-y</ArticleId><ArticleId IdType="pmc">PMC9543931</ArticleId><ArticleId IdType="pubmed">36207334</ArticleId></ArticleIdList></Reference><Reference><Citation>Escalera A, Gonzalez-Reiche AS, Aslam S, Mena I, Laporte M, Pearl RL, et al. . Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe. (2022) 30:373–387.e7. doi: 10.1016/j.chom.2022.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.01.006</ArticleId><ArticleId IdType="pmc">PMC8776496</ArticleId><ArticleId IdType="pubmed">35150638</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, et al. . Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. (2022) 603:700–5. doi: 10.1038/s41586-022-04462-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04462-1</ArticleId><ArticleId IdType="pmc">PMC8942852</ArticleId><ArticleId IdType="pubmed">35104835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, et al. . Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. (2020) 61:103104. doi: 10.1016/j.ebiom.2020.103104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103104</ArticleId><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differentiation. (2021) 28:2019–21. doi: 10.1038/s41418-021-00795-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00795-y</ArticleId><ArticleId IdType="pmc">PMC8114657</ArticleId><ArticleId IdType="pubmed">33981020</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Tortorici MA, Snijder J, Xiong X, Bosch B-J, Rey FA, et al. . Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci. (2017) 114:11157–62. doi: 10.1073/pnas.1708727114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708727114</ArticleId><ArticleId IdType="pmc">PMC5651768</ArticleId><ArticleId IdType="pubmed">29073020</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, et al. . Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. (2022) 602:300–6. doi: 10.1038/s41586-021-04266-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04266-9</ArticleId><ArticleId IdType="pmc">PMC8828475</ArticleId><ArticleId IdType="pubmed">34823256</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Wu C, Cao X, Gu C, Liu H, Jiang M, et al. . Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins. Cell Res. (2022) 32:609–20. doi: 10.1038/s41422-022-00672-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00672-4</ArticleId><ArticleId IdType="pmc">PMC9152305</ArticleId><ArticleId IdType="pubmed">35641567</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann PJ, Iida S, Iwatsuki-Horimoto K, Maemura T, Kiso M, Scheaffer SM, et al. . SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. (2022) 603:687–92. doi: 10.1038/s41586-022-04441-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04441-6</ArticleId><ArticleId IdType="pmc">PMC8942849</ArticleId><ArticleId IdType="pubmed">35062015</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon ACM, Darling TL, Halfmann PJ, Franks J, Webby RJ, Barouch DH, et al. . Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters. PloS Pathog. (2022) 18:e1010970. doi: 10.1371/journal.ppat.1010970</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010970</ArticleId><ArticleId IdType="pmc">PMC9718401</ArticleId><ArticleId IdType="pubmed">36459536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Z, Liu P, Wang N, Wang L, Fan K, Zhu Q, et al. . Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. (2022) 185:860–871.e13. doi: 10.1016/j.cell.2022.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.019</ArticleId><ArticleId IdType="pmc">PMC8786603</ArticleId><ArticleId IdType="pubmed">35120603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Ye Z-W, Liang R, Tang K, Zhang AJ, Lu G, et al. . Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science. (2022) 377:428–33. doi: 10.1126/science.abn8939</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8939</ArticleId><ArticleId IdType="pubmed">35737809</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. . BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. (2022) 608:593–602. doi: 10.1038/s41586-022-04980-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04980-y</ArticleId><ArticleId IdType="pmc">PMC9385493</ArticleId><ArticleId IdType="pubmed">35714668</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusawa Y, Kiso M, Iida S, Uraki R, Hirata Y, Imai M, et al. . In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters. eBioMedicine. (2023) 91:104561. doi: 10.1016/j.ebiom.2023.104561</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104561</ArticleId><ArticleId IdType="pmc">PMC10083686</ArticleId><ArticleId IdType="pubmed">37043872</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W, Choy KT, Gu H, Sia SF, Cheng KM, Nizami SIN, et al. . Reduced pathogenicity and transmission potential of omicron BA.1 and BA.2 sublineages compared with the early severe acute respiratory syndrome coronavirus 2 D614G variant in Syrian hamsters. J Infect Dis. (2022) 227(10):1143-52. doi: 10.1093/infdis/jiac276</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac276</ArticleId><ArticleId IdType="pmc">PMC9278237</ArticleId><ArticleId IdType="pubmed">35776136</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann PJ, Uraki R, Kuroda M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, et al. . Transmission and re-infection of Omicron variant XBB.1.5 in hamsters. eBioMedicine. (2023) 93:104677. doi: 10.1016/j.ebiom.2023.104677</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104677</ArticleId><ArticleId IdType="pmc">PMC10329098</ArticleId><ArticleId IdType="pubmed">37352827</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaub JM, Chou C-W, Kuo H-C, Javanmardi K, Hsieh C-L, Goldsmith J, et al. . Expression and characterization of SARS-CoV-2 spike proteins. Nat Protoc. (2021) 16:5339–56. doi: 10.1038/s41596-021-00623-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-021-00623-0</ArticleId><ArticleId IdType="pmc">PMC9665560</ArticleId><ArticleId IdType="pubmed">34611365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z. Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain*. J Biol Chem. (2010) 285:14681–8. doi: 10.1074/jbc.M109.067090</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.067090</ArticleId><ArticleId IdType="pmc">PMC2863243</ArticleId><ArticleId IdType="pubmed">20197275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang W, Wang T, Wang J, Jiang Y, Wang X, et al. . SARS-coV-2 ORF8 protein induces endoplasmic reticulum stress-like responses and facilitates virus replication by triggering calnexin: an unbiased study. J Virol. (2023) 97:e00011–23. doi: 10.1128/jvi.00011-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00011-23</ArticleId><ArticleId IdType="pmc">PMC10062165</ArticleId><ArticleId IdType="pubmed">36877072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhao Y, Yan F, Wang T, Sun W, Feng N, et al. . Viral and host transcriptomes in SARS-coV-2-infected human lung cells. J Virol. (2021) 95:e00600–21. doi: 10.1128/JVI.00600-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00600-21</ArticleId><ArticleId IdType="pmc">PMC8387032</ArticleId><ArticleId IdType="pubmed">34106002</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitt MA. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virological Methods. (2010) 169:365–74. doi: 10.1016/j.jviromet.2010.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.08.006</ArticleId><ArticleId IdType="pmc">PMC2956192</ArticleId><ArticleId IdType="pubmed">20709108</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong M, Lin H, Pan M, Huang M, Liu M, Jiang R, et al. . Characterization of the SARS-coV-2 BA.5 variants in H11-K18-hACE2 hamsters. bioRxiv. (2024), 227 (10):1143–1152. doi: 10.1101/2024.02.19.581112</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.19.581112</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>